Treatment of severe cardiac contusion with a left ventricular assist device in a patient with multiple trauma  by Chavanon, Olivier et al.
Myocardial contusion has potentially lethal complications.1
In cases of refractory cardiogenic shock the use of an intra-
aortic balloon pump (IABP) is a therapeutic option,2,3 but a
left ventricular assist device (LVAD) is not generally used
because of the risk of posttraumatic bleeding.
Clinical summary.  A 22-year-old woman was injured in
an automobile crash, with resulting blunt trauma. On admis-
sion she had minor cranial trauma (Glasgow Coma Scale
score of 13 and no intracranial hematoma on computed tomo-
graphic scan), facial trauma, and a chest injury with pul-
monary contusion and myocardial contusion (electrocardio-
gram showing lateral ST-segment and T-wave changes;
troponin Ic levels [reference range is 0-1.5 m g/L] of 4.6 m g/L
on admission, 24.1 m g/L the first day, and 32 m g/L the second
day; creatine kinase levels [reference range is 0-110 IU/L] of
4070 IU/L on admission, 2967 IU/L the first day, and 5607
IU/L the second day; and creatine kinase isoenzyme MB lev-
els [reference range is 0-4 IU/L] of 191.2 IU/L on admission,
153.8 IU/L the first day, and 100.8 IU/L the second day) but
without rib or sternal fracture. She also had various fractures
(left humeral fracture, tibiofibular fractures in both legs, and
major pelvic ring injury) and a major abdominal injury neces-
sitating an urgent operation (resection of 10 cm ileum and
suture of traumatic vesicovaginal fistula).
When taken to the operating room she had a brief cardiac
arrest, followed by a second one in the recovery room (from
both of which she was immediately resuscitated). Cardiogenic
shock was documented with a thermodilution catheter (Swan-
Ganz catheter; Baxter Healthcare Corp, Edwards Division,
Santa Ana, Calif). With inotropic support (1.3 m g · kg–1 · min–1
epinephrine and 16 m g · kg–1 · min–1 dobutamine) the patient
had a cardiac index of 1.9 L/min, an arterial pressure of
134/92 mm Hg, a pulmonary artery pressure of 31/22 mm Hg,
a central venous pressure of 16 mm Hg, a pulmonary capillary
wedge pressure of 22 mm Hg, and a venous oxygen saturation
of 55%. A transesophageal echocardiogram showed a left
ventricular ejection fraction (LVEF) of 0.25, with diffuse
hypokinesia and left ventricular enlargement confirming
myocardial contusion. A percutaneous IABP was therefore
inserted. After brief improvement, acute ischemia of the right
lower limb concurrent with degradation of her hemodynamic
status led to the removal of the IABP the next day. A decision
was made to institute LVAD use 72 hours after the accident
because, despite maximal inotropic support, the patient had
anuria and her cardiac index was 1.9 L/min, her arterial pres-
sure was 74/43 mm Hg, her central venous pressure was 15
mm Hg, her pulmonary capillary wedge pressure was 22 mm
Hg, her venous oxygen saturation was 50%, and her LVEF
was 0.20 (Fig 1).
A Bio-Medicus centrifugal pump (Bio-Pump; Medtronic
Bio-Medicus, Inc, Minneapolis, Minn) was implanted
through a median sternotomy with right superior pulmonary
venous cannulation by a 30F wire-reinforced right-angle can-
nula (JOSTRA Medizintechnik AG, Hirrlingen, Germany)
and aortic cannulation with a Sarns 20F cannula (3M Health
Care, Ann Arbor, Mich), connected to an extracorporeal
bypass circuit with a Carmeda BioActive Surface (Carmeda
AB, Stockholm, Sweden). The device output of 3 L/min (total
cardiac output of 4.1 L/min) allowed gradual hemodynamic
stabilization and progressive reduction of inotropic support.
No heparin was used at that time. Revascularization of the
lower limb was performed at the same time and completed
with a fasciotomy. On arrival at the intensive care unit the
patient had an arterial pressure of 107/75 mm Hg, a pul-
monary arterial pressure of 19/10 mm Hg, a pulmonary capil-
lary wedge pressure of 7 mm Hg, a central venous pressure of
9 mm Hg, and normal arterial blood gas values. No bleeding
occurred, allowing continuous infusion of low-dose heparin
(12,000 IU/24 h).
Postoperative echocardiography showed progressive recov-
ery of left ventricular motion and normal right ventricular size
(Fig 2). The patient was weaned from LVAD output at the end
of postoperative day 5, and the LVAD was removed on post-
operative day 6. At that time the LVEF had increased to 0.50
with low doses of dobutamine (8 m g–1 · kg–1 · min).
Unfortunately, the right lower limb had to be amputated on
postoperative day 8. The patient was operated on for orthope-
dic lesions on postoperative days 12 and 19 and was dis-
charged 68 days after the initial operation. On postoperative
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day 19 the LVEF reached 0.70. Follow-up is satisfactory at 7
months.
Comment. Use of an IABP in cases of severe myocardial
contusion is a therapeutic option but it has limited effective-
ness.2,3 Furthermore, an IABP may induce vascular compli-
cations,4 which are more frequent in female patients because
of their smaller vessels,5 as was the case in our patient (body
surface area of 1.5 m2). Despite the high mortality rate asso-
ciated with severe myocardial contusion, no alternatives to
medical treatment and IABP use have been described. To our
knowledge no similar use of an LVAD for myocardial contu-
sion in a patient with multiple trauma has been previously
reported. Although no cerebral lesion was diagnosed in our
patient, we used an LVAD as a last resort because of the
bleeding and septic risks associated with the severe abdomi-
nal and pelvic injury. The indications for an LVAD were the
need to remove the IABP to restore blood flow to the limb
and the continued degradation of the patient’s hemodynamic
status. Although amputation of the right lower limb was
unfortunately necessary, the LVAD allowed recovery of the
severely contused myocardium within 6 days, which is a sat-
isfactory clinical result after life-threatening cardiogenic
shock. As long as there is no significant head trauma, initial
LVAD insertion should be considered in such cases with
severe myocardial contusion, refractory cardiogenic shock,
and a high risk of vascular complications. High-flow cen-
trifugal pump support and use of heparin-bonded bypass cir-
cuits allow minimization of heparin administration and con-
sequently of the risk of bleeding.
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Fig 1. Transesophageal echocardiogram (short-axis view and
M-mode echocardiogram) before implantation of LVAD
shows severe diffuse hypokinesia of left ventricle and dilation
of right ventricle with good contractility.
Fig. 2. Transesophageal echocardiogram (short-axis view and
M-mode echocardiogram) 4 days after implantation of LVAD
shows recovery of global left ventricular function and recov-
ery of right ventricular size and thickening.
